Amneal Pharmaceuticals (AMRX) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Amneal Pharmaceuticals, as the data feed reports them.

Analysts' mean target, 7 analysts
$24.29
15.0% above the price

The 7 analysts reported by the data feed have a mean price target for Amneal Pharmaceuticals of $24.29, 15.0% above the $21.12 price (range $20.00–$28.00). 4.64% of the float was sold short as of Oct 30, 2026. Institutions hold 50.7% of the shares and insiders 52.1%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$24.29+15.0% vs price
Analysts
7
Short interest
4.64%of float, Oct 30, 2026
Short ratio
2.86 days
Institutions
50.7%
Insiders
52.08%
Beta
1.21

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

7 analysts covering Amneal Pharmaceuticals, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $21.12.

Analysts' price targets for Amneal Pharmaceuticals
Mean price target$24.2915.0% above the price (+15.0%)
Median price target$25.0018.4% above the price (+18.4%)
Highest target$28.0032.6% above the price (+32.6%)
Lowest target$20.005.3% below the price (−5.3%)
Analysts with a target7

Ratings this month · 7 analysts

Strong buy 3(43%)Buy 4(57%)
Analysts' ratings of Amneal Pharmaceuticals this month, by rating
RatingAnalystsShare
Strong buy343%
Buy457%
Hold00%
Sell00%
Strong sell00%

The feed averages these to 1.43 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Amneal Pharmaceuticals

Ownership of Amneal Pharmaceuticals
Held by institutions50.7%462 institutions; percent of shares outstanding
Held by institutions, of the float105.8%
Held by insiders52.08%percent of shares outstanding
Shares outstanding348.41M
Float215.33Mshares available to trade
Insiders' net purchases, six months+25.68M9 purchases (26.09M shares), 3 sales (413.02K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Amneal Pharmaceuticals
Shares short11.39Mas of Oct 30, 2026
Percent of float4.64%shares short ÷ float
Percent of shares outstanding3.27%shares short ÷ shares outstanding
Short ratio (days to cover)2.86shares short ÷ average daily volume

Amneal Pharmaceuticals short interest from FINRA, with its history

Trading figures

Trading figures for Amneal Pharmaceuticals
Beta1.21movement against the market; 1 moves with it
52-week high$22.07
52-week low$11.39
Average volume, 3 months3.14Mshares a day
Average volume, 10 days3.58Mshares a day

Questions and answers

What is the analysts' price target for Amneal Pharmaceuticals (AMRX)?

As reported by the data feed, the mean price target of the 7 analysts covering Amneal Pharmaceuticals is $24.29, 15.0% above the latest price of $21.12. The highest target is $28.00 and the lowest $20.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Amneal Pharmaceuticals stock?

Of the 7 ratings the data feed reports for the current month, 3 are strong buy, 4 buy, 0 hold, 0 sell and 0 strong sell.

How many Amneal Pharmaceuticals shares are sold short?

As reported by the data feed, 11.39M shares were sold short, 4.64% of the float as of Oct 30, 2026. At the average daily volume that is 2.86 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Amneal Pharmaceuticals stock?

As reported by the data feed, institutions hold 50.7% of the shares (462 institutions) and insiders 52.1%. There are 348.41M shares outstanding, of which 215.33M are in the float.

How much does Amneal Pharmaceuticals stock move with the market?

Its beta, as reported by the data feed, is 1.21: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $11.39 and $22.07.

Cite this page

Funkfolio, “Amneal Pharmaceuticals (AMRX) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/AMRX/statistics

Underlying data: Yahoo Finance.